This test is most useful if any of these apply to you.
If your thyroid is off, your energy, weight, mood, heart rhythm, and even your long-term risk of fractures and heart attack can drift with it. Free T4 is the number that tells you how much active thyroid hormone your body actually has available to use, not just how loudly your pituitary is shouting at your thyroid gland.
Most doctors start thyroid testing with TSH alone, and for many people that is enough. TSH remains the guideline-recommended first-line thyroid test. But TSH can look normal while your actual hormone levels are wrong, especially if the problem lives in your pituitary rather than your thyroid, if you are on thyroid medication, or if you are pregnant or seriously ill. Free T4 is the complementary test that helps settle those questions.
Your thyroid gland produces mostly thyroxine, abbreviated T4, which acts as a reservoir hormone that your tissues convert into the more active form, T3, wherever it is needed. Almost all of the T4 in your blood travels bound to carrier proteins. Only about 0.03% floats free. That tiny free fraction is FT4 (free thyroxine), and it is the portion your cells can actually use.
Because carrier protein levels change with pregnancy, birth control pills, liver disease, and inherited variation, total T4 can rise or fall without your real hormone status changing at all. FT4 sidesteps that problem by measuring the biologically usable pool directly.
Even within the normal range, higher FT4 predicts atrial fibrillation, an irregular heart rhythm that raises the risk of stroke. In a study of 174,914 patients, people in the highest quarter of FT4 within the normal range had about 40% higher odds of already having atrial fibrillation and about 16% higher risk of developing it, compared to people in the lowest quarter. A large individual participant data meta-analysis of over 30,000 euthyroid participants found a similar pattern, with about 45% higher risk of new atrial fibrillation in the highest versus lowest FT4 quartile.
This is one of the strongest reasons to care about FT4 even when your TSH looks fine. A normal-range FT4 that sits near the top of the range is not neutral for your heart.
In the general adult population, higher FT4 has been linked to greater risk of cardiovascular disease and death. One large individual participant data meta-analysis of over 134,000 participants found that people in the top fifth of FT4 had roughly 34% higher all-cause mortality and 57% higher cardiovascular mortality compared with people in the middle of the range. A separate NHANES-based analysis focusing on the FT3/FT4 ratio reported associations in the same direction, roughly on the order of 15 to 18% per standard-deviation change, though that study's primary focus was the ratio rather than FT4 alone. In elderly men with a normal TSH, higher FT4 tracked with roughly 23% higher mortality and 25% higher risk of new cardiovascular events, driven mainly by cerebrovascular events (stroke and related conditions), which showed about 56% higher risk.
The direction of risk is not one-size-fits-all. In critically ill and septic patients, low FT4 on admission was independently linked to higher short-term mortality, likely reflecting the biology of severe acute illness rather than a general protective effect of high FT4.
This is not a paradox. FT4 behaves as a marker of chronic thyroid tone in stable outpatients, where higher levels push the heart and bones toward harm over years. In acute severe illness, low FT4 mostly reflects how sick the person is, not a chronic hormone problem. The right way to interpret your FT4 depends on whether you are stable or acutely ill, and on what your TSH, symptoms, and medications say alongside it.
Higher FT4 also appears to weaken bone over time. In a large pooled analysis of over 56,000 euthyroid participants, each standard-deviation higher FT4 was linked to about 22% higher hip fracture risk. In one study of older men, those in the top quarter of FT4 had roughly 50% higher hip fracture risk than the rest, even when TSH looked normal. Thyroid hormone speeds up bone turnover, and running high, even inside the reference range, appears to tip the balance toward loss. Not every study agrees, though. At least one cohort of older men found no significant association between FT4 and hip fracture, so this is a real signal but not a universal one.
In older adults being watched for frailty, each 0.1 ng/dL rise in FT4 was associated with about 14% higher risk of losing physical function. Those in the top FT4 quintile had roughly nine times the risk of functional decline compared to those in the middle, while those in the lowest quintile had about half the risk. These figures come from a single, relatively small geriatric outpatient cohort, so the size of the effect may not generalize, but the direction is consistent with broader work linking higher FT4 to frailty in older adults.
For most healthy people, an abnormal TSH is the first sign of thyroid trouble, and current guidelines still recommend TSH as the first-line screening test. But there are important situations where TSH is unreliable and FT4 becomes the deciding test. In central hypothyroidism, the pituitary itself is not sending the right signal, so TSH stays in the normal range even though the thyroid is underperforming. Only a low FT4 catches this pattern.
FT4 is also the more reliable measurement during the first months of thyroid treatment, after dose changes, in subacute thyroiditis, in pregnancy, and in serious non-thyroidal illness, because TSH can lag behind or drift away from the true thyroid state. In one single-center study, FT4 alone identified thyroid disorders with 91% sensitivity and 94% specificity, and combining FT4 with TSH pushed both to 98%. That study comes from a smaller journal and does not overturn TSH's role as the first-line test, but it supports pairing the two when the clinical picture is unclear.
A single FT4 reading has real limits. Assay-to-assay differences alone can shift the number by 10 to 20% or more, and normal within-person biological variation adds another few percent on top of that. That means one borderline result rarely tells the whole story, especially near the top or bottom of the range.
Getting a baseline, retesting in 3 to 6 months if you are starting or adjusting thyroid medication, and rechecking at least yearly if you are stable gives you a trajectory. A trend that steadily drifts toward the upper or lower end of the range is more informative than any single number, and it lets you catch a subtle problem before it forces a diagnosis. If you switch labs or the assay method changes, ideally repeat your test on the same platform you have been tracking, because different assays are not directly interchangeable.
FT4 assays are technically fragile. Several situations can push a single reading in the wrong direction without any real thyroid change:
Certain medications can also nudge FT4 without indicating true thyroid disease. High-dose aspirin, IV furosemide above 80 mg, phenytoin, carbamazepine, and rifampin are each known to shift the number, sometimes by 10 to 30% or more depending on the drug and dose. If you are on any of these, share that with whoever is reading your result.
If your FT4 comes back outside the expected range or does not match your TSH, the next steps depend on the pattern, not just the number:
Ordering TSH, Free T3, and thyroid antibodies alongside FT4 gives the full picture. Reverse T3 and total T4 can help sort out complex or discordant cases. If FT4 and TSH tell different stories after a repeat, that is when an endocrinologist earns their fee.
Evidence-backed interventions that affect your Free T4 level
Free T4 is best interpreted alongside these tests.
Free T4 is included in these pre-built panels.